首页 > 最新文献

Alergologia Polska - Polish Journal of Allergology最新文献

英文 中文
Details and effects of pre-hospital pharmacotherapy in pediatric population patients with anaphylactic or severe allergic symptoms – a single-center study 有过敏或严重过敏症状的儿科患者院前药物治疗的细节和效果-一项单中心研究
IF 0.2 Pub Date : 2022-01-01 DOI: 10.5114/pja.2022.116286
Mateusz Piętak, Maksymilian Sroczyński, Filip Jesionowski, Jan Stachurski
Introduction: Anaphylaxis is an acute, potentially life-threatening, systemic hypersensitivity reaction. Its prevalence in pediatric population is constantly increasing. Adrenaline is a first-line treatment in every case of anaphylaxis. Aim: To examine the details of anaphylaxis treatment in the pre-hospital setting in a pediatric population. We wanted to determine whether there is a correlation between pharmacotherapy being implemented during the Emergency Medical Services (EMS) interventions and subsequent admission to the hospital. Material and methods: In our retrospective study, we
简介:过敏反应是一种急性的、可能危及生命的全身性超敏反应。其在儿科人群中的患病率不断上升。肾上腺素是所有过敏反应的一线治疗药物。目的:探讨过敏反应治疗的细节在院前设置在儿科人群。我们想要确定在紧急医疗服务(EMS)干预期间实施的药物治疗与随后入院之间是否存在相关性。材料与方法:在回顾性研究中,我们
{"title":"Details and effects of pre-hospital pharmacotherapy in pediatric population patients with anaphylactic or severe allergic symptoms – a single-center study","authors":"Mateusz Piętak, Maksymilian Sroczyński, Filip Jesionowski, Jan Stachurski","doi":"10.5114/pja.2022.116286","DOIUrl":"https://doi.org/10.5114/pja.2022.116286","url":null,"abstract":"Introduction: Anaphylaxis is an acute, potentially life-threatening, systemic hypersensitivity reaction. Its prevalence in pediatric population is constantly increasing. Adrenaline is a first-line treatment in every case of anaphylaxis. Aim: To examine the details of anaphylaxis treatment in the pre-hospital setting in a pediatric population. We wanted to determine whether there is a correlation between pharmacotherapy being implemented during the Emergency Medical Services (EMS) interventions and subsequent admission to the hospital. Material and methods: In our retrospective study, we","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70480437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostics of peanut allergy – part I 花生过敏的诊断-第一部分
IF 0.2 Pub Date : 2022-01-01 DOI: 10.5114/pja.2022.119228
Julia Gawryjołek, A. Krogulska
{"title":"Diagnostics of peanut allergy – part I","authors":"Julia Gawryjołek, A. Krogulska","doi":"10.5114/pja.2022.119228","DOIUrl":"https://doi.org/10.5114/pja.2022.119228","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70481091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse effects of vaccinations and potential therapies against COVID-19 针对COVID-19疫苗接种的不良影响和潜在疗法
IF 0.2 Pub Date : 2022-01-01 DOI: 10.5114/pja.2022.114392
K. Wasiak, P. Rieske
Publication indicates that antiviral therapies are definitely more harmful and less effective as well as less accessible than vaccinations. Antiviral therapies are generally not effective in phase II and III of the disease. The use of antiviral therapies in all patients would doom them to many side effects, and only 10% of patients go from phase I to phase II and require such treatment. The chance of curing COVID-19 patients in phase II and III of the disease is rapidly declining. Vaccinations, on the other hand, are very effective. Confirmed AEFI are rare and intensive research is underway to elucidate their etiopathogenesis. From a biotechnological point of view, vaccination leads to the production of CAR-T-like immunotherapy or monoclonal antibodies, that work from the 1st day of infection, not from the first day of symptom onset, when patients can start some pharmacological therapy. In the case of COVID-19, a clear advantage of vaccination over pharmacological therapy has emerged. Nevertheless, because vaccination may not be effective for all patients, working on therapy should also be intensively carried out. Proper pharmacotherapy administration depends on the quick cooperation of diagnosticians with doctors. It also depends on the development of tests to select therapies and determine in whom a disease such as COVID-19 will change from phase I to phase II. Vaccinated patients will probably respond better to treatments.
出版物表明,抗病毒疗法肯定比疫苗更有害,效果更差,也更难以获得。抗病毒治疗通常在疾病的II期和III期无效。在所有患者中使用抗病毒治疗将导致许多副作用,只有10%的患者从第一阶段进入第二阶段并需要这种治疗。新冠肺炎二期和三期患者的治愈机会正在迅速下降。另一方面,接种疫苗是非常有效的。确诊的急性脑损伤非常罕见,目前正在进行深入的研究以阐明其发病机制。从生物技术的角度来看,疫苗接种导致产生car - t样免疫疗法或单克隆抗体,这些抗体从感染的第一天起起作用,而不是从症状出现的第一天起起作用,此时患者可以开始一些药物治疗。就COVID-19而言,疫苗接种明显优于药物治疗。然而,由于疫苗接种可能并非对所有患者都有效,因此也应集中开展治疗工作。适当的药物治疗管理取决于诊断医师与医生的快速合作。这还取决于测试的发展,以选择治疗方法,并确定COVID-19等疾病将从第一阶段转变为第二阶段。接种疫苗的患者可能会对治疗有更好的反应。
{"title":"Adverse effects of vaccinations and potential therapies against \u0000COVID-19","authors":"K. Wasiak, P. Rieske","doi":"10.5114/pja.2022.114392","DOIUrl":"https://doi.org/10.5114/pja.2022.114392","url":null,"abstract":"Publication indicates that antiviral therapies are definitely more harmful and less effective as well as less accessible than vaccinations. Antiviral therapies are generally not effective in phase II and III of the disease. The use of antiviral therapies in all patients would doom them to many side effects, and only 10% of patients go from phase I to phase II and require such treatment. The chance of curing COVID-19 patients in phase II and III of the disease is rapidly declining. Vaccinations, on the other hand, are very effective. Confirmed AEFI are rare and intensive research is underway to elucidate their etiopathogenesis. From a biotechnological point of view, vaccination leads to the production of CAR-T-like immunotherapy or monoclonal antibodies, that work from the 1st day of infection, not from the first day of symptom onset, when patients can start some pharmacological therapy. In the case of COVID-19, a clear advantage of vaccination over pharmacological therapy has emerged. Nevertheless, because vaccination may not be effective for all patients, working on therapy should also be intensively carried out. Proper pharmacotherapy administration depends on the quick cooperation of diagnosticians with doctors. It also depends on the development of tests to select therapies and determine in whom a disease such as COVID-19 will change from phase I to phase II. Vaccinated patients will probably respond better to treatments.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70480014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
House dust mite sensitivity in atopic children with Dectin-1 rs7309123 polymorphism Dectin-1 rs7309123多态性儿童屋尘螨敏感性研究
IF 0.2 Pub Date : 2022-01-01 DOI: 10.5114/pja.2022.119232
O. Mozyrska
{"title":"House dust mite sensitivity in atopic children with Dectin-1 rs7309123 polymorphism","authors":"O. Mozyrska","doi":"10.5114/pja.2022.119232","DOIUrl":"https://doi.org/10.5114/pja.2022.119232","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70480850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human papillomavirus (HPV) – assessing the level of knowledge, sexual behaviours, awareness, attitude, and vaccination status among dentistry students 人乳头瘤病毒(HPV)——评估牙科学生的知识水平、性行为、意识、态度和疫苗接种状况
IF 0.2 Pub Date : 2022-01-01 DOI: 10.5114/pja.2022.118967
M. Michalak, T. Milecki, Jakub Milecki, Maciej Rembisz, K. Klimczak, Aneta Choręziak, W. Cieślikowski, A. Antczak
{"title":"Human papillomavirus (HPV) – assessing the level of knowledge, sexual behaviours, awareness, attitude, and vaccination status among dentistry students","authors":"M. Michalak, T. Milecki, Jakub Milecki, Maciej Rembisz, K. Klimczak, Aneta Choręziak, W. Cieślikowski, A. Antczak","doi":"10.5114/pja.2022.118967","DOIUrl":"https://doi.org/10.5114/pja.2022.118967","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70480969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The safety of celecoxib in cutaneous hypersensitivityreactions with nonsteroidal anti-inflammatory drugs:a single-center care experience 塞来昔布在非甾体抗炎药皮肤过敏反应中的安全性:单中心护理经验
IF 0.2 Pub Date : 2022-01-01 DOI: 10.5114/pja.2022.122005
M. Çakmak
{"title":"The safety of celecoxib in cutaneous hypersensitivity\u0000reactions with nonsteroidal anti-inflammatory drugs:\u0000a single-center care experience","authors":"M. Çakmak","doi":"10.5114/pja.2022.122005","DOIUrl":"https://doi.org/10.5114/pja.2022.122005","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70481362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the harmfulness of smoking tobacco cigarettes versus heat-not-burn tobacco in patients with asthma 吸烟对哮喘患者的危害与加热非燃烧烟草的比较
IF 0.2 Pub Date : 2021-01-01 DOI: 10.5114/PJA.2021.106686
Artur Nowak, R. Pawliczak
Asthma is a heterogeneous disease characterized by chronic inflammation of the airways with symptoms such as wheezing, shortness of breath, chest tightness and coughing of varying frequency and severity, with varying degrees of airway obstruction. Many factors have a significant influence on the course of asthma, including smoking. The harmful effects of cigarettes have been known for a long time and pose a unique threat to people suffering from asthma. Exposure to passive inhalation of tobacco smoke and active smoking can lead to exac-erbation of the disease, wheezing, coughing and shortness of breath. Tobacco smoke irritates the respiratory system and damages the cilia. Continued exposure to cigarette smoke in the environment also increases the risk of other respiratory diseases such as bronchitis, pneumonia and lung cancer.
哮喘是一种异质性疾病,其特征是气道慢性炎症,症状包括不同频率和严重程度的喘息、呼吸短促、胸闷和咳嗽,并伴有不同程度的气道阻塞。许多因素对哮喘的病程有显著影响,包括吸烟。香烟的有害影响早已为人所知,它对哮喘患者构成了独特的威胁。被动吸入烟草烟雾和主动吸烟可导致疾病加重、喘息、咳嗽和呼吸短促。烟草烟雾刺激呼吸系统,损害纤毛。在环境中持续接触香烟烟雾也会增加患支气管炎、肺炎和肺癌等其他呼吸系统疾病的风险。
{"title":"Comparison of the harmfulness of smoking tobacco cigarettes versus heat-not-burn tobacco in patients with asthma","authors":"Artur Nowak, R. Pawliczak","doi":"10.5114/PJA.2021.106686","DOIUrl":"https://doi.org/10.5114/PJA.2021.106686","url":null,"abstract":"Asthma is a heterogeneous disease characterized by chronic inflammation of the airways with symptoms such as wheezing, shortness of breath, chest tightness and coughing of varying frequency and severity, with varying degrees of airway obstruction. Many factors have a significant influence on the course of asthma, including smoking. The harmful effects of cigarettes have been known for a long time and pose a unique threat to people suffering from asthma. Exposure to passive inhalation of tobacco smoke and active smoking can lead to exac-erbation of the disease, wheezing, coughing and shortness of breath. Tobacco smoke irritates the respiratory system and damages the cilia. Continued exposure to cigarette smoke in the environment also increases the risk of other respiratory diseases such as bronchitis, pneumonia and lung cancer.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genome editing in therapy: immunological context 治疗中的基因组编辑:免疫学背景
IF 0.2 Pub Date : 2021-01-01 DOI: 10.5114/pja.2021.111801
P. Rieske
obie-cujące lub mukowiscydozie. Edycja genomu autogennych T z chimerycznym receptorem antygenowym ( chimeric antigen receptor T-cells – CAR-T). Edycja genomu w połączeniu z technologią iPSc powinna umożliwić otrzymanie tzw. uniwersalnych komórek do transplantacji, w tym uniwersalnych CAR-T. Edycja genomu jest więc szczególnie istotna kontekście immunologicznym. abStract Genome editing of induced pluripotent stem cells (iPSc) or hematopoietic tolerancji immunologicznej, ale ta zmienna jest istotna [4, 5]. Chorób warunkowanych występowaniem mutacji typu nonsens jest wiele, symptoms depend on blood cell dysfunction than, for example, in muscular dystrophy or cystic fibrosis. Genome editing is also used to refine autogenous T cells with chimeric antigen receptor T-cells (CAR-T). Finally, genome editing in combination with iPSc technology should enable the production of the so-called universal for transplantation, including universal CAR-T. Genome editing is therefore particularly important in an immunological context.
双极性或囊性纤维化。用嵌合抗原受体T细胞(CAR-T)编辑自体T基因组。基因组编辑与iPSc技术相结合,应该可以获得所谓的。通用移植细胞,包括通用CAR-T。因此,基因组编辑是一个特别重要的免疫背景。abStract诱导多能干细胞(iPSc)或造血免疫耐受的基因组编辑,但该变量是相关的[4,5]。以无义突变发生为条件的疾病有很多,症状取决于血细胞功能障碍,而不是肌肉营养不良或囊性纤维化。基因组编辑也被用于用嵌合抗原受体T细胞(CAR-T)纯化自体T细胞。最后,基因组编辑与iPSc技术相结合,应该能够产生所谓的通用移植,包括通用CAR-T。因此,基因组编辑在免疫学方面尤为重要。
{"title":"Genome editing in therapy: immunological context","authors":"P. Rieske","doi":"10.5114/pja.2021.111801","DOIUrl":"https://doi.org/10.5114/pja.2021.111801","url":null,"abstract":"obie-cujące lub mukowiscydozie. Edycja genomu autogennych T z chimerycznym receptorem antygenowym ( chimeric antigen receptor T-cells – CAR-T). Edycja genomu w połączeniu z technologią iPSc powinna umożliwić otrzymanie tzw. uniwersalnych komórek do transplantacji, w tym uniwersalnych CAR-T. Edycja genomu jest więc szczególnie istotna kontekście immunologicznym. abStract Genome editing of induced pluripotent stem cells (iPSc) or hematopoietic tolerancji immunologicznej, ale ta zmienna jest istotna [4, 5]. Chorób warunkowanych występowaniem mutacji typu nonsens jest wiele, symptoms depend on blood cell dysfunction than, for example, in muscular dystrophy or cystic fibrosis. Genome editing is also used to refine autogenous T cells with chimeric antigen receptor T-cells (CAR-T). Finally, genome editing in combination with iPSc technology should enable the production of the so-called universal for transplantation, including universal CAR-T. Genome editing is therefore particularly important in an immunological context.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypersensitivity reaction after Procto-Glyvenol application 原甘炔醇应用后过敏反应
IF 0.2 Pub Date : 2021-01-01 DOI: 10.5114/PJA.2021.109383
Ewelina Kasprzyk-Wieczorkowska, Edyta Jura-Szołtys, Olga Branicka, R. Gawlik
Treatment of haemorrhoidal disease is very often based on the local application of suppositories or creams. These preparations are widespread and often available over the counter. Most of the measures it contains several active ingredients, including painkillers, vasoprotectors or local anesthetics. In some cases, combined treatment is used. Drug hypersensitivity reaction is best understood and described for immediate reactions occurring mainly after the use of antibiotics, non-steroidal anti-inflammatory drugs or local anesthetics. This article highlights the importance of substances with rare describe hypersensitivity reactions. A case of patient with hypersensitivity to Procto-Glyvenol, a drug contain tribenoside and lignocaine. In the diagnostic process emphasizes the use of epidermal patch testing as an essential test in response to topical agents and in reactions delayed. Drug hypersensitivity reactions to tribenoside are very little known and rarely reported.
痔疮疾病的治疗通常基于局部应用栓剂或药膏。这些制剂很普遍,通常可以在柜台上买到。大多数措施都含有几种有效成分,包括止痛药、血管保护剂或局部麻醉剂。在某些情况下,采用联合治疗。对药物超敏反应最好的理解和描述是主要在使用抗生素、非甾体抗炎药或局部麻醉剂后发生的立即反应。这篇文章强调了与罕见的物质描述过敏反应的重要性。对含有三苯诺苷和利多卡因的原甘维醇过敏的病人1例。在诊断过程中,强调使用表皮斑贴试验作为对局部药物反应和延迟反应的基本试验。对三苯甲苷的药物超敏反应鲜为人知,也很少报道。
{"title":"Hypersensitivity reaction after Procto-Glyvenol application","authors":"Ewelina Kasprzyk-Wieczorkowska, Edyta Jura-Szołtys, Olga Branicka, R. Gawlik","doi":"10.5114/PJA.2021.109383","DOIUrl":"https://doi.org/10.5114/PJA.2021.109383","url":null,"abstract":"Treatment of haemorrhoidal disease is very often based on the local application of suppositories or creams. These preparations are widespread and often available over the counter. Most of the measures it contains several active ingredients, including painkillers, vasoprotectors or local anesthetics. In some cases, combined treatment is used. Drug hypersensitivity reaction is best understood and described for immediate reactions occurring mainly after the use of antibiotics, non-steroidal anti-inflammatory drugs or local anesthetics. This article highlights the importance of substances with rare describe hypersensitivity reactions. A case of patient with hypersensitivity to Procto-Glyvenol, a drug contain tribenoside and lignocaine. In the diagnostic process emphasizes the use of epidermal patch testing as an essential test in response to topical agents and in reactions delayed. Drug hypersensitivity reactions to tribenoside are very little known and rarely reported.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome and the risk of severe COVID-19 哮喘、慢性阻塞性肺疾病(COPD)和哮喘-COPD重叠综合征以及严重COVID-19的风险
IF 0.2 Pub Date : 2021-01-01 DOI: 10.5114/PJA.2021.104655
Klaudia Waszczykowska, Marta Węgierska, Roxana Drygała, R. Pawliczak
Asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome (ACOS) significantly affect the patient's respiratory system, which requires individualised treatment and professional control During the SARS-CoV-2 pandemic, all respiratory diseases were taken into consideration as risk factors for severe COVID-19 ACE2 and TMPRSS2 genes, which are crucial for SARS-CoV-2 to enter the host cell, have different expression in the occurrence of asthma or COPD Also, comparing the severity and mortality of patients with coexistence of asthma or COPD and COVID-19, only COPD patients had worse outcomes of COVID-19, and their mortality was significantly higher Although ACOS is also a potential risk factor for hospitalisation and mortality in COVID-19 patients, the condition still requires further studies This overview presents the current state of knowledge on the relationship between the diseases mentioned above and COVID-19
哮喘、慢性阻塞性肺疾病(COPD)和哮喘-COPD重叠综合征(ACOS)显著影响患者的呼吸系统,需要个体化治疗和专业控制。在SARS-CoV-2大流行期间,所有呼吸道疾病都被认为是严重COVID-19的危险因素,ACE2和TMPRSS2基因在哮喘或COPD的发生中表达不同,而ACE2和TMPRSS2基因是SARS-CoV-2进入宿主细胞的关键基因。对比哮喘或COPD与COVID-19共存患者的严重程度和死亡率,只有COPD患者的COVID-19预后较差,且死亡率明显高于COPD患者。尽管ACOS也是COVID-19患者住院和死亡的潜在危险因素,但仍需进一步研究
{"title":"Asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome and the risk of severe COVID-19","authors":"Klaudia Waszczykowska, Marta Węgierska, Roxana Drygała, R. Pawliczak","doi":"10.5114/PJA.2021.104655","DOIUrl":"https://doi.org/10.5114/PJA.2021.104655","url":null,"abstract":"Asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome (ACOS) significantly affect the patient's respiratory system, which requires individualised treatment and professional control During the SARS-CoV-2 pandemic, all respiratory diseases were taken into consideration as risk factors for severe COVID-19 ACE2 and TMPRSS2 genes, which are crucial for SARS-CoV-2 to enter the host cell, have different expression in the occurrence of asthma or COPD Also, comparing the severity and mortality of patients with coexistence of asthma or COPD and COVID-19, only COPD patients had worse outcomes of COVID-19, and their mortality was significantly higher Although ACOS is also a potential risk factor for hospitalisation and mortality in COVID-19 patients, the condition still requires further studies This overview presents the current state of knowledge on the relationship between the diseases mentioned above and COVID-19","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Alergologia Polska - Polish Journal of Allergology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1